A hidden strategy: How SARS-CoV-2 uses fibrinogen to evade the immune system
As scientists, we often think we understand a virus—its structure, its tricks, the way it moves through the body. But every ...
BioWorld4d
Shionogi’s S-880008 shows broad range of activity against SARS-CoV-2 variants
COVID-19 has continued to alarm public health, and although several therapeutics and vaccines have been developed, the development of effective vaccines or antibodies is challenging due to mutations ...
AllAfrica on MSN4d
Africa: A New Covid Variant Is On the Rise. Here's What to Know About LP.8.1
Analysis - More than five years since COVID was declared a pandemic, we're still facing the regular emergence of new variants ...
What to know about the new Covid strain affecting three in five UK patients
The latest variant on the rise is LP.8.1. It’s increasing in Australia, making up close to one in five COVID cases in New ...
Physician's Weekly2d
Molnupiravir Impact on Viral Clearance and Treatment Duration
The following is a summary of “A viro-immunological model to characterize the antiviral effect of molnupiravir in SARS-CoV-2-infected outpatients: implication for treatment duration,” published in the ...
Researchers develop nasal spray H5N1 avian influenza vaccine
The State Key Laboratory for Emerging Infectious Diseases at the University of Hong Kong (HKU) and the InnoHK Center for ...
Flu Vaccines Available for 2025: Understanding Your Options and Recommendations
In Australia, flu vaccines are accessible for individuals aged six months and older. While the vaccines may have limited efficacy in very young infants, pregnant mothers can provide their newborns ...